Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
WBSCR22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
WDR19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM213 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FNDC10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NETO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LMO4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LEPROT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NOB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NDUFV2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGAP33 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPOCK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
NCDN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNB5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NADK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LY6K - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UCHL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on